Arkolith/Insider Trading/AADI/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Mar 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Sell(S)6K$2.35$13K33K
Mar 1, 2025Option exercise(M)16K——39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2025Option exercise(M)16K—$049K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006316) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Aadi Bioscience, Inc.

Build

Ask your agent about AADI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-25-006316"
Ask your agent
Use Arkolith to summarize insider buying and selling at Aadi Bioscience, Inc.
over the last 90 days and cite the filings.